Different compounders add different inactive ingredients (vitamin B12, niacinamide, or other substances), use different preparation methods, and provide different storage instructions
Pilot study of anti-Th2 immunotherapy for the treatment of breast cancer-related upper extremity lymphedema
The FDA's findings reveal a complete absence of the data governance infrastructure required for regulated manufacturing
Khoramipour K, Hosseini NS, Hill JW, Khoramipour K, Khoramipour K, Izquierdo SM, et al
Moreover, different tissues and organs have varying tolerance thresholds for TMAO, and further clarification is still required on whether the dynamic fluctuations of TMAO exert beneficial roles or detrimental effects in human organs
Headache is reported by approximately 1015% of patients and usually resolves within the first month of therapy